Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Mark F McLaughlin"'
Publikováno v:
PLoS ONE, Vol 15, Iss 11, p e0241505 (2020)
IntroductionRadiation-induced lymphopenia (RIL) occurs during treatment with conventional radiation in multiple organ sites. Development of RIL portends poor prognosis. Stereotactic body radiation therapy (SBRT) spares RIL in pancreatic cancer, but h
Externí odkaz:
https://doaj.org/article/51fa6f9b34bc4ca197e1a8521fab3a2e
Autor:
Mark F McLaughlin, Jonathan Woodward, Rose A Boll, Jonathan S Wall, Adam J Rondinone, Stephen J Kennel, Saed Mirzadeh, J David Robertson
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e54531 (2013)
Targeted radiotherapies maximize cytotoxicty to cancer cells. In vivo α-generator targeted radiotherapies can deliver multiple α particles to a receptor site dramatically amplifying the radiation dose delivered to the target. The major challenge wi
Externí odkaz:
https://doaj.org/article/1a3a1583aa87460787fc214aaf7959c6
Autor:
Raquibul Hannan, Mark F. McLaughlin, Laurentiu M. Pop, Ivan Pedrosa, Payal Kapur, Aurelie Garant, Chul Ahn, Alana Christie, James Zhu, Tao Wang, Liliana Robles, Deniz Durakoglugil, Solomon Woldu, Vitaly Margulis, Jeffrey Gahan, James Brugarolas, Robert Timmerman, Jeffrey Cadeddu
Publikováno v:
European Urology.
Autor:
Vitaly Margulis, Yair Lotan, Xiaosong Meng, Jeffrey Howard, Neil Desai, Andre Miranda, Aditya Bagrodia, Raquibul Hannan, Aurelie Garant, Mark F. McLaughlin, Solomon L. Woldu
Publikováno v:
Journal of Urology. 206
INTRODUCTION AND OBJECTIVE:Metastasis-directed radiation therapy (MDRT) may improve oncologic and quality of life outcomes in patients with metastatic cancer, but data on its use in metastatic blad...
Autor:
Mark F. McLaughlin, Steven J. Hudak, Neil Desai, Raquibul Hannan, Michael R. Folkert, Aurelie Garant, Daniel N. Costa, Robert Timmerman
Publikováno v:
Advances in Radiation Oncology
Advances in Radiation Oncology, Vol 6, Iss 4, Pp 100713-(2021)
Advances in Radiation Oncology, Vol 6, Iss 4, Pp 100713-(2021)
The risk of rectal toxicity during and after prostate cancer radiation therapy is common to all treatment regimens. Hydrogel rectal spacers are increasingly being used to mitigate this risk and to facilitate dose-escalation, but also may infiltrate t
Autor:
Yair Lotan, Timothy Clinton, Oner Sanli, Raquibul Hannan, Aditya Bagrodia, Solomon L. Woldu, Andre Miranda, Aurelie Garant, Mark F. McLaughlin, Vitaly Margulis, Xiaosong Meng, Jeffrey Howard, Neil Desai
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 39:790.e1-790.e7
Purpose Metastasis-directed radiation therapy (MDRT) may improve oncologic and quality of life outcomes in patients with metastatic cancer, but data on its use in metastatic bladder cancer is severely limited. We sought to review our institutional ex
Publikováno v:
Aerospace Medicine and Human Performance. 88:665-676
BACKGROUND In the space environment, the traditional radioprotective principles of time, distance, and shielding become difficult to implement. Additionally, the complex radiation environment inherent in space, the chronic exposure timeframe, and the
Autor:
Morshed Alam, Chi Lin, Michael J. Baine, Jeffrey M. Ryckman, Lynnette Smith, Mark F. McLaughlin
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 11, p e0241505 (2020)
PLoS ONE, Vol 15, Iss 11, p e0241505 (2020)
Introduction Radiation-induced lymphopenia (RIL) occurs during treatment with conventional radiation in multiple organ sites. Development of RIL portends poor prognosis. Stereotactic body radiation therapy (SBRT) spares RIL in pancreatic cancer, but
Autor:
Douglas C. Miller, Tiffany Remsen, Marshall C. Cress, Mark F. McLaughlin, Angela N. Spurgeon, J. David Robertson, Paul H. Pevsner
Publikováno v:
Journal of Nanomaterials & Molecular Nanotechnology. 5
Crossing the Blood-Brain Barrier with Antibody-Labeled, Gold-Coated Nanoconjugates: A Preliminary Step in Targeting and Eradicating Brain Tumors This paper shows ultrastructural proof of principle that antibodylabeled nanoconjugates can cross the blo